EDGAR Filing Documents for 9999999995-23-000290

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-23-000290

Accepted

2023-02-07 00:15:07

Documents

Effectiveness Date

2023-02-06

Registration Form

S-3

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	593
	Complete submission text file	9999999995-23-000290.txt		1854

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807

Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300

RVL Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-269440 | Film No.: 23592627
SIC: 2834 Pharmaceutical Preparations